4.8 million Americans ages 12 and older were diagnosed with cannabis use disorder in 2019. As of 2020, there are 35 states in which medical marijuana is legal, and 1 in 5 total states where cannabis is recreationally legal. Yet, on a national level, cannabis remains a schedule I substance under the Controlled Substances Act - limiting research on the drug. With cannabis becoming more readily available in multiple states, psychiatrists and other mental health professionals need to have the most updated information available on cannabis and to help patients make informed decisions.
Join the American Psychiatric Association (APA) and the American Academy of Addiction Psychiatry (AAAP) for a two-part webinar series to learn about cannabis. The first webinar will provide an overview and updates on cannabis use in patients, mental health impacts and clinical practice recommendations based on the latest research, and the second will provide a follow up session to provide more insights and answer attendee questions on cannabis in psychiatry/addiction psychiatry patients based on the latest research.
We encourage you to complete the brief survey to help us better tailor our content and to submit questions related to cannabis: https://bit.ly/3l5R5fL